BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Eyedea Medical awarded competitive National Science Foundation Phase II Small Business Innovation Research Grant, Baltimore, MD

  Eyedea Medical, a Baltimore-based medtech startup working to alleviate the burden of corneal blindness through innovative solutions in corneal transplantation and eye banking, has been awarded a $1,000,000 Phase II Small Business Innovation Research grant from the National Science Foundation.

  February 23, 2023

   · 

  2 min read
• Business

  Cartography Biosciences Appoints Chester Wong as VP, Head of Business Development

  Cartography Biosciences announced the appointment of Chester Wong as Vice President, Head of Business Development.

  February 23, 2023

   · 

  3 min read
• Deals

  Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F

  Qilian International Holding Group Ltd today announced it has received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on February 16, 2023.

  February 23, 2023

   · 

  3 min read
• Business

  Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates

  Shattuck Labs, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided recent business highlights.

  February 23, 2023

   · 

  17 min read
• Business

  Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

  Generation Bio Co outlined its strategic priorities for 2023 and reported fourth quarter and full year 2022 financial results.

  February 23, 2023

   · 

  7 min read
• Deals

  Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million

  Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced the completion of its previously announced merger.

  February 23, 2023

   · 

  7 min read
• Business

  CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (23% constant currency)

  Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months and full year ended December 31, 2022.

  February 23, 2023

   · 

  18 min read
• Business

  Vapotherm Reports Fourth Quarter and Fiscal Year 2022 Financial Results

  Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced fourth quarter and fiscal year 2022 financial results.

  February 23, 2023

   · 

  24 min read
• BioForest

  National Experts Available for Rare Disease Day: February 28, 2023

  February 28th marks Rare Disease Day – a day designated to driving awareness and change for the more than 25 million Americans and 300 million people worldwide living and struggling with a rare disease.

  February 23, 2023

   · 

  1 min read
• CMS Temporarily Suspends Medicare Payments to Modern Vascular

  On February 9, 2023, Modern Vascular facilities received letters from the CMS program wherein the facilities were advised that Medicare Payments to Modern Vascular are suspended pending the outcome of the current DOJ lawsuit.

  February 23, 2023

   · 

  2 min read